Cover Image

Use of generic medication for epilepsy: valproic acid

-

Saved in:

Bibliographic Details
Main Authors:	Carmona Aparicio Liliana (Author), Chávez Pacheco Juan Luis (Author), Alemón Medina Radamés (Author)
Format:	Book
Published:	Instituto Nacional de Pediatría, 2014-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Generic drugs for epilepsy: application criteria
by: Carmona Aparicio Lliliana, et al.
Published: (2014)

Physicochemical stability of three generic brands of metformin in solution
by: Radamés Alemón-Medina, et al.
Published: (2014)

Valproic Acid and Sleep Duration in Children with Epilepsy
by: J Gordon Millichap
Published: (2009)

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
by: J Gordon Millichap
Published: (2010)

Cost analysis of epilepsy pharmacotherapy by valproic acid and carbamazepine
by: Ia. O. Grynkiv, et al.
Published: (2018)

Serum concentrations of valproic acid in people with epilepsy: Clinical implication
by: Angel T. Alvarado, et al.
Published: (2022)

Physicochemical stability of a metformin solution from three commercial brands
by: Alemón Medina Radamés, et al.
Published: (2014)

Long-Term Effectiveness of Ethosuximide, Valproic Acid and Lamotrigine in Absence Epilepsy
by: J Gordon Millichap
Published: (2012)

Correlation Between Pyridoxal 5'-Phospate Level And Valproic Acid In Epilepsy Children
by: I Gusti Ngurah Made Suwarba, et al.
Published: (2019)

Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy
by: Tiantian Liang, et al.
Published: (2024)

Quantification of metformin and glyburide in blood for paediatric endocrinology
by: Radamés Alemón-Medina, et al.
Published: (2014)

Valproic Acid and Thrombocytopenia
by: J Gordon Millichap
Published: (1996)

Citotoxicidad de los edulcorantes Splenda® y Svetia® en formulaciones extemporáneas pediátricas
by: Cynthia Sámano-Salazar, et al.
Published: (2015)

The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
by: Hady Yazbeck, et al.
Published: (2024)

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
by: Jiahao Zhu, et al.
Published: (2023)

Comparison of monotherapy effect of phenytoin, carbamazapine and valproic acid in pediatric general tonic clonic and partial epilepsy
by: Muchamad Budi Nugroho, et al.
Published: (2008)

Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in Dictyostelium discoideum
by: Elizabeth Kelly, et al.
Published: (2018)

Hepatic Fatalities and Valproic Acid
by: J Gordon Millichap
Published: (1996)

Choreiform Movements and Valproic Acid
by: J Gordon Millichap
Published: (1994)

Valproic Acid and Carnitine Metabolism
by: J Gordon Millichap
Published: (1991)

Effect of <i>Helicobacter pylori</i> Eradication on Serum Level of Valproic Acid in Children with Idiopathic Generalized Epilepsy
by: Abobakr Abdelgalil, et al.
Published: (2024)

Valproic Acid-Associated Liver Failure
by: J Gordon Millichap
Published: (2011)

Ammonia Blood Levels and Valproic Acid
by: J Gordon Millichap
Published: (2007)

Hallucinations after Valproic Acid Withdrawal
by: J Gordon Millichap
Published: (2012)

Valproic Acid-Induced Hair Curling
by: J Gordon Millichap
Published: (2007)

Thrombophilic Risk Factors with Valproic Acid
by: J Gordon Millichap
Published: (2009)

Treatment of Infantile Spasms with Valproic Acid
by: Taslim S. Soetomenggolo
Published: (2019)

Effects of valproic acid on skeletal metabolism in children with epilepsy: a systematic evaluation and meta-analysis based on 14 studies
by: Li Min, et al.
Published: (2020)

Comparative analysis of valproic acid concentrations in terms of dosing and clinical effect monitoring in different age patients with diagnosed epilepsy
by: Agnieszka Cios, et al.
Published: (2022)

The Effect of Carnitine Supplementation on Blood Ammonia Level in Epilepsy Children Treated with Valproic Acid: A Randomized Controlled Trial
by: I Gusti Lanang Sidiartha, et al.
Published: (2021)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
by: Lee SY, et al.
Published: (2015)

Synthesis of valproic acid derivatives using pyridoxine as pro-moiety
by: Chalermkiat Songkram
Published: (2014)

Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy
by: Ze-Yue Xu, et al.
Published: (2021)

Liquid chromatography-tandem mass spectrometry method for simultaneous determination of valproic acid and its ene-metabolites in epilepsy patient plasma
by: Huan Lu, et al.
Published: (2016)

Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study
by: Lina Zhang, et al.
Published: (2023)

Considerations in perioperative assessment of valproic acid coagulopathy
by: Claude Abdallah
Published: (2014)

An ode to valproic acid: A letter to the editor
by: Anna P. Shapiro-Krew, et al.
Published: (2024)

Neonatal Intractable Seizures and Valproic acid Therapy
by: J Gordon Millichap
Published: (1988)

Severe Valproic Acid Intoxication Responding to Hemodialysis
by: Ali Ertuğ Arslanköylü, et al.
Published: (2017)

Therapeutic monitoring of valproic acid - benefits and problems
by: Agnieszka Małgorzata Cios, et al.
Published: (2021)